Journal of Clinical Endocrinology & Metabolism, Vol 76, 44-48, Copyright © 1993 by Endocrine Society

ARTICLES

Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance

GM Reaven, YD Chen, CB Hollenbeck, WH Sheu, D Ostrega and KS Polonsky
Department of Medicine, Stanford University School of Medicine, California.

Conventional immunoassays to quantify insulin concentration do not differentiate between insulin and proinsulin. Thus, previous conclusions as to the relationship between the development of hyperglycemia in patients with noninsulin-dependent diabetes mellitus (NIDDM) and pancreatic insulin secretory function may have been confounded by not being able to determine the contribution made by plasma proinsulin to the putative measurements of plasma insulin concentration in these patients. The current study was initiated to address this issue by making specific measurements of plasma insulin, proinsulin, and C-peptide concentrations in 42 individuals: 14 with normal glucose tolerance, 12 with impaired glucose tolerance (IGT), and 16 with NIDDM. The study population was further subdivided into a nonobese (body mass index, < 30 kg/m2) and an obese (body mass index, > 30 kg/m2) group. Mixed meals were given at 0800, 1200, and 1800 h, and blood was removed at 0800 h (before the meal) and at hourly intervals from then until 1600 h. Plasma glucose concentrations throughout the sampling period were slightly, but significantly (P < 0.01), greater in patients with IGT than in normal individuals. Patients with NIDDM had markedly elevated glycemic excursions, greater than either of the other two groups (P < 0.002). Both plasma immunoreactive insulin and C- peptide concentrations from 0800-1600 h were higher (P < 0.002-0.001) in patients with either IGT or NIDDM than in the group with normal glucose tolerance. Although day-long plasma immunoreactive insulin and C-peptide concentrations were higher, on the average, in patients with IGT compared to those with NIDDM, the difference was not statistically significant. Plasma proinsulin concentrations were highest in patients with NIDDM (P < 0.002), lower in those with normal glucose tolerance (P < 0.002), and intermediate in patients with IGT. When the calculated "true" insulin concentration was determined by taking the proinsulin content into consideration, patients with IGT had the highest day-long levels, with the lowest values found in the control population (P < 0.002). Although absolute values varied as a function of obesity, the generalizations outlined above were found in both weight groups. These results show that ambient plasma proinsulin concentrations increase as glucose tolerance declines. However, true plasma insulin concentrations in response to mixed meals remain highest in patients with IGT, lowest in normal individuals, and intermediate in patients with NIDDM. Thus, previous conclusions that absolute day-long plasma insulin concentrations are not lower than normal in patients with NIDDM do not appear to result from an inability to differentiate true insulin from proinsulin.

This article has been cited by other articles:

				J. Erdmann, B. Kallabis, U. Oppel, O. Sypchenko, S. Wagenpfeil, and V. Schusdziarra Development of hyperinsulinemia and insulin resistance during the early stage of weight gain Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E568 - E575. [Abstract] [Full Text] [PDF]

				Y.-X. Meng, E. S. Ford, C. Li, A. Quarshie, A. M. Al-Mahmoud, W. Giles, G. H. Gibbons, and G. Strayhorn Association of C-Reactive Protein with Surrogate Measures of Insulin Resistance among Nondiabetic US Adults: Findings from National Health and Nutrition Examination Survey 1999 2002 Clin. Chem., December 1, 2007; 53(12): 2152 - 2159. [Abstract] [Full Text] [PDF]

				R. Sapin Insulin Immunoassays: Fast Approaching 50 Years of Existence and Still Calling for Standardization Clin. Chem., May 1, 2007; 53(5): 810 - 812. [Full Text] [PDF]

				C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]

				The Diabetes Prevention Program Research Group Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program: Effects of Lifestyle Intervention and Metformin Diabetes, August 1, 2005; 54(8): 2404 - 2414. [Abstract] [Full Text] [PDF]

				R. M. Witteles, W. H. W. Tang, A. H. Jamali, J. W. Chu, G. M. Reaven, and M. B. Fowler Insulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link J. Am. Coll. Cardiol., July 7, 2004; 44(1): 78 - 81. [Abstract] [Full Text] [PDF]

				H. J Petrie, S. E Chown, L. M Belfie, A. M Duncan, D. H McLaren, J. A Conquer, and T. E Graham Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss Am. J. Clinical Nutrition, July 1, 2004; 80(1): 22 - 28. [Abstract] [Full Text] [PDF]

				S. Ten and N. Maclaren Insulin Resistance Syndrome in Children J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2526 - 2539. [Abstract] [Full Text] [PDF]

				G. Reaven, F. Abbasi, and T. McLaughlin Obesity, Insulin Resistance, and Cardiovascular Disease Recent Prog. Horm. Res., January 1, 2004; 59(1): 207 - 223. [Abstract] [Full Text]

				M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF]

				V. Seshadri, P. L. Fox, and C. K. Mukhopadhyay Dual Role of Insulin in Transcriptional Regulation of the Acute Phase Reactant Ceruloplasmin J. Biol. Chem., July 26, 2002; 277(31): 27903 - 27911. [Abstract] [Full Text] [PDF]

				R. S. Legro, R. Bentley-Lewis, D. Driscoll, S. C. Wang, and A. Dunaif Insulin Resistance in the Sisters of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2128 - 2133. [Abstract] [Full Text] [PDF]

				R. Sinha, G. Fisch, B. Teague, W. V. Tamborlane, B. Banyas, K. Allen, M. Savoye, V. Rieger, S. Taksali, G. Barbetta, et al. Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity N. Engl. J. Med., March 14, 2002; 346(11): 802 - 810. [Abstract] [Full Text] [PDF]

				A. J. G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M. S. Wolever, J. Kwan, and B. Zinman Cross-Sectional and Prospective Associations between Abdominal Adiposity and Proinsulin Concentration J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 77 - 83. [Abstract] [Full Text] [PDF]

				F. A. Khan, P. B. Goforth, M. Zhang, and L. S. Satin Insulin Activates ATP-Sensitive K+ Channels in Pancreatic {beta}-Cells Through a Phosphatidylinositol 3-Kinase-Dependent Pathway Diabetes, October 1, 2001; 50(10): 2192 - 2198. [Abstract] [Full Text]

				A. E. Hak, H. A. P. Pols, C. D. A. Stehouwer, J. Meijer, A. J. Kiliaan, A. Hofman, M. M. B. Breteler, and J. C. M. Witteman Markers of Inflammation and Cellular Adhesion Molecules in Relation to Insulin Resistance in Nondiabetic Elderly: The Rotterdam Study J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4398 - 4405. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, G. McKeown-Eyssen, S. B. Harris, R. A. Hegele, T. M.S. Wolever, J. Kwan, P. W. Connelly, and B. Zinman Cross-Sectional and Prospective Associations Between Proinsulin and Cardiovascular Disease Risk Factors in a Population Experiencing Rapid Cultural Transition Diabetes Care, July 1, 2001; 24(7): 1240 - 1247. [Abstract] [Full Text] [PDF]

				L. Bokemark, J. Wikstrand, and B. Fagerberg Intact Insulin, Insulin Propeptides, and Intima-media Thickness in the Femoral Artery in 58-year-old Clinically Healthy Men: The Atherosclerosis and Insulin Resistance Study Angiology, April 1, 2001; 52(4): 237 - 245. [Abstract] [PDF]

				R. C. Perry, R. R. Shankar, N. Fineberg, J. McGill, and A. D. Baron HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose: The Early Diabetes Intervention Program (EDIP) Diabetes Care, March 1, 2001; 24(3): 465 - 471. [Abstract] [Full Text]

				J. Ciric, Z. Penezic, and M. Drezgic Effect of Weight Loss on the Pulsatile Insulin Secretion J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3673 - 3677. [Abstract] [Full Text]

				J. C. ter Maaten, E. H. Serne, W. S. van Eps, P. M. ter Wee, A. J. M. Donker, and R. O. B. Gans Effects of insulin and atrial natriuretic peptide on renal tubular sodium handling in sickle cell disease Am J Physiol Renal Physiol, March 1, 2000; 278(3): F499 - F505. [Abstract] [Full Text] [PDF]

				F. Abbasi, T. McLaughlin, C. Lamendola, H. Yeni-Komshian, A. Tanaka, T. Wang, K. Nakajima, and G. M. Reaven Fasting Remnant Lipoprotein Cholesterol and Triglyceride Concentrations Are Elevated in Nondiabetic, Insulin-Resistant, Female Volunteers J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3903 - 3906. [Abstract] [Full Text]

				B. Fruehwald-Schultes, W. Kern, W. Bong, P. Wellhoener, W. Kerner, J. Born, H. L. Fehm, and A. Peters Supraphysiological Hyperinsulinemia Acutely Increases Hypothalamic-Pituitary-Adrenal Secretory Activity in Humans J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3041 - 3046. [Abstract] [Full Text]

				H. Larsson and B. Ahrén Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2068 - 2074. [Abstract] [Full Text]

				S. M. Haffner, R. D'Agostino Jr, L. Mykkanen, C. N. Hales, P. J. Savage, R. N. Bergman, D. O'Leary, M. Rewers, J. Selby, R. Tracy, et al. Proinsulin and Insulin Concentrations in Relation to Carotid Wall Thickness : Insulin Resistance Atherosclerosis Study Stroke, August 1, 1998; 29(8): 1498 - 1503. [Abstract] [Full Text] [PDF]

				M. Deberg, P. Houssa, B. H. Frank, F. Sodoyez-Goffaux, and J.-C. Sodoyez Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors Clin. Chem., July 1, 1998; 44(7): 1504 - 1513. [Abstract] [Full Text] [PDF]

				P. Houssa, B. Dinesen, M. Deberg, B. H. Frank, C. Van Schravendijk, F. Sodoyez-Goffaux, and J.-C. Sodoyez First direct assay for intact human proinsulin Clin. Chem., July 1, 1998; 44(7): 1514 - 1519. [Abstract] [Full Text] [PDF]

				P.-W. Wang, F. Abbasi, M. Carantoni, Y.-D. I. Chen, S. Azhar, and G. M. Reaven Insulin Resistance Does Not Change the Ratio of Proinsulin to Insulin in Normal Volunteers J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3221 - 3224. [Abstract] [Full Text] [PDF]

				J. P. Toyry, L. K. Niskanen, M. J. Mantysaari, E. A. Lansimies, S. M. Haffner, H. J.J. Miettinen, and M. I.J. Uusitupa Do High Proinsulin and C-Peptide Levels Play a Role in Autonomic Nervous Dysfunction? : Power Spectral Analysis in Patients With Non–Insulin-Dependent Diabetes and Nondiabetic Subjects Circulation, August 19, 1997; 96(4): 1185 - 1191. [Abstract] [Full Text]

				P. Bavenholm, A. Proudler, P. Tornvall, I. Godsland, C. Landou, U. de Faire, and A. Hamsten Insulin, Intact and Split Proinsulin, and Coronary Artery Disease in Young Men Circulation, September 15, 1995; 92(6): 1422 - 1429. [Abstract] [Full Text]